CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Cancer Network
Original article

<![CDATA[IMS 2026: Key Updates Across The Multiple Myeloma Paradigm]]>

ConferencevenetoclaxdaratumumabNeutral
AI Analysis

Summary

IMS 2026 conference featured poster presentations on venetoclax and daratumumab use in various combination regimens for multiple myeloma treatment settings.

Importance:3/10
Sentiment:
0.00
multiple myelomaconference presentationvenetoclaxdaratumumabtreatment combination

Read the original article

Published by Cancer Network on October 1, 2026 5:00 PM

Read Original